Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

First patient treated in phase I advanced AMD study of Litx

March 1, 2005

No Comments

GenVec expands testing of AdPEDF for AMD

Feb. 24, 2005

No Comments

Enrollment targets met in two phase II studies of squalamine for AMD

Feb. 17, 2005

No Comments

Phase III data on the effects of diquafosol ophthalmic solution in patients with dry eye

Feb. 15, 2005

No Comments

Novartis inlicenses rebamipide for dry eye

Feb. 9, 2005

No Comments

Phase III confirmatory study of Photrex planned

Feb. 4, 2005

No Comments

Pharmos receives milestone for Zylet launch

Jan. 26, 2005

No Comments

Macugen now available

Jan. 25, 2005

No Comments

Jerini and Alcon collaborate on novel ophthalmology drugs

Jan. 24, 2005

No Comments

Phase II study evaluates recombinant microplasmin in vitreoretinal disorders

Jan. 21, 2005

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

First patient treated in phase I advanced AMD study of Litx

GenVec expands testing of AdPEDF for AMD

Enrollment targets met in two phase II studies of squalamine for AMD

Phase III data on the effects of diquafosol ophthalmic solution in patients with dry eye

Novartis inlicenses rebamipide for dry eye

Phase III confirmatory study of Photrex planned

Pharmos receives milestone for Zylet launch

Macugen now available

Jerini and Alcon collaborate on novel ophthalmology drugs

Phase II study evaluates recombinant microplasmin in vitreoretinal disorders

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Ocular RSS

Ocular
RSS